^
BIOMARKER:

CCND1 amplification

i
Other names: CCND1, BCL1, D11S287E, PRAD1, U21B31, Cyclin D1
Entrez ID:
Related biomarkers:
CCND1 amplification
Melanoma
sorafenib
Sensitive: B - Late Trials
CCND1 amplification
Estrogen Receptor Positive Breast Cancer
palbociclib
Resistant: C3 – Early Trials
CCND1 amplification
Solid Tumor
Immunotherapy
Resistant: C3 – Early Trials
CCND1 amplification
Breast Cancer
Aromatase inhibitor
Resistant: C3 – Early Trials
CCND1 amplification
Melanoma
ribociclib
Sensitive: C3 – Early Trials
CCND1 amplification
Lung Non-Small Cell Squamous Cancer
palbociclib
Sensitive: C3 – Early Trials
CCND1 amplification
Melanoma
toripalimab
Resistant: C3 – Early Trials
CCND1 amplification
Head and Neck Cancer
cetuximab + palbociclib
Sensitive: C3 – Early Trials
CCND1 amplification
Breast Cancer
lapatinib
Sensitive: D – Preclinical